Kulisewa, Kazione
Dussault, Josée M.
Gaynes, Bradley N.
Hosseinipour, Mina C.
Go, Vivian F.
Kutengule, Anna
LeMasters, Katherine
Meltzer-Brody, Samantha
Midiani, Dalitso
Mphonda, Steven M.
Udedi, Michael
Pence, Brian W.
Bengtson, Angela M.
Funding for this research was provided by:
Fogarty International Center (D43TW010060)
National Institute of Allergy and Infectious Diseases (T32AI070114)
National Institute of Mental Health (R34MH116806, R34MH116806, R34MH116806, R34MH116806)
National Institute of Child Health and Human Development (T32HD091058)
Agency for Healthcare Research and Quality (T32HS000032)
National Institute on Drug Abuse (R25DA037190)
Center for AIDS Research, University of North Carolina at Chapel Hill (P30AI050410, P30AI050410, P30AI050410)
Article History
Received: 18 January 2022
Accepted: 15 December 2022
First Online: 29 December 2022
Declarations
:
: This study was approved by the Institutional Review Boards at the University of North Carolina at Chapel Hill (UNC IRB #17–2396) and at the Malawi National Health Sciences Research Committee (NHSRC). If participants were literate, written informed consent was obtained. If participants were illiterate, oral informed consent was obtained, participants subsequently stamped their thumbprint in place of a signature, and their name and the date of informed consent was written in print; an impartial witness was present and provided their written attestation of the participant’s informed consent as well. All study methods were carried out in accordance with relevant guidelines and regulations. All informed consent forms and procedures were shared with and approved by the UNC IRB (#17–2396) and Malawi NHSRC (#1903).
: All participants provided written informed consent for this research, including the potential for the interview content to be communicated in publications in a de-identified format.
: The authors have declared that they have no competing interests.